ScholarIQanswers from OpenAlex

Curcumin suppresses TGF-β signaling by inhibition of TGIF degradation in scleroderma fibroblasts

PaperCitations, authors & open-access status

Curcumin suppresses TGF-β signaling by inhibition of TGIF degradation in scleroderma fibroblasts is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Curcumin suppresses TGF-β signaling by inhibition of TGIF degradation in scleroderma fibroblasts have?

ScholarIQcitation count

Curcumin suppresses TGF-β signaling by inhibition of TGIF degradation in scleroderma fibroblasts has 48 citations in the OpenAlex counts ScholarIQ stores.

When was Curcumin suppresses TGF-β signaling by inhibition of TGIF degradation in scleroderma fibroblasts published?

ScholarIQyear

Curcumin suppresses TGF-β signaling by inhibition of TGIF degradation in scleroderma fibroblasts has 2011 year in the ScholarIQ index.

What is the open-access status of Curcumin suppresses TGF-β signaling by inhibition of TGIF degradation in scleroderma fibroblasts?

ScholarIQoa status

Curcumin suppresses TGF-β signaling by inhibition of TGIF degradation in scleroderma fibroblasts has closed oa status in the ScholarIQ index.

What is the DOI of Curcumin suppresses TGF-β signaling by inhibition of TGIF degradation in scleroderma fibroblasts?

ScholarIQdoi

The DOI for Curcumin suppresses TGF-β signaling by inhibition of TGIF degradation in scleroderma fibroblasts is on the source record.

What is the PMID of Curcumin suppresses TGF-β signaling by inhibition of TGIF degradation in scleroderma fibroblasts?

ScholarIQpmid

The PMID for Curcumin suppresses TGF-β signaling by inhibition of TGIF degradation in scleroderma fibroblasts is on the source record.

What is the OpenAlex record for Curcumin suppresses TGF-β signaling by inhibition of TGIF degradation in scleroderma fibroblasts?

ScholarIQopenalex

The OpenAlex for Curcumin suppresses TGF-β signaling by inhibition of TGIF degradation in scleroderma fibroblasts is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial